In the phase 3 PANOVA-3 trial, adding Tumor Treating Fields therapy to gemcitabine and nab-paclitaxel was associated with improved overall survival and delayed pain progression in adults with locally advanced pancreatic cancer.
Forced deployments to immigration detention are pushing US public health clinicians to resign—and raising urgent questions about medical ethics, obedience, and harm.